Viola Ventures

General Partners Shlomo Dovrat, Avi Zeevi, Harel Beit-On, and Danny Cohen lead investment decisions. Dovrat and Zeevi co-founded the firm in 2000 and steer overall strategy. The partnership structure means no single GP holds unilateral decision authority — commitments are made by consensus among the senior team.

The firm relies on deep university networks — particularly the Technion and Tel Aviv University — and military intelligence Unit 8200 alumni, the primary feeder for Israeli cybersecurity and AI founders. The broader Viola Group platform, spanning credit and growth-stage funds, generates early visibility into companies that later require venture-stage capital. Viola Ventures often meets founders at formation, before institutional rounds begin.

Yes, it is the venture arm of Viola Group, which also includes Viola Credit, Viola Growth, and Viola FinTech. The group collectively manages over $4.5B, making it Israel's largest dedicated technology investment platform. Each entity operates with its own team and investment committee, but the shared brand and LP network create cross-entity dealflow and co-investment opportunities.

Viola Ventures makes direct equity investments in private companies. It does not operate as a fund-of-funds and does not commit capital to other venture firms. The group's credit arm provides venture debt, which portfolio companies can access independently of equity rounds, but the venture arm itself focuses on direct minority-stake investing.

The firm invests from seed through Series B, with initial check sizes typically ranging from $1M to $15M. It leads or co-leads rounds and reserves significant capital for follow-on investments as portfolio companies scale. The emphasis is on being the first institutional investor or joining at the earliest institutional round.

Viola Ventures concentrates on software, deep tech, and digital infrastructure. It generally avoids hard-science biotech, medical devices requiring FDA approval, and capital-intensive clean-energy hardware. The firm prefers asset-light, IP-driven business models where Israeli technical talent provides a competitive moat.

Funds are structured as Israeli limited partnerships with parallel vehicles for US and European institutional LPs. The GP entity is based in Herzliya, and fund documents include standard side-letter provisions for tax-exempt investors. LPs gain exposure to Israeli tech exits through a structure that accommodates US dollar-denominated commitments and distributions.